Patents by Inventor Paul D. Gordon

Paul D. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355432
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: June 29, 2023
    Publication date: November 9, 2023
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 11723798
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: August 15, 2023
    Assignee: Gyroscope Therapeutics Limited
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Publication number: 20210007890
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 10821021
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: November 3, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 10219936
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, a cannula actuation assembly, and a needle actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The cannula actuation assembly is operable to actuate the cannula relative to the body. The needle actuation assembly is operable to actuate the needle relative to the cannula. The cannula may be inserted through a sclerotomy to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: March 5, 2019
    Assignee: ORBIT BIOMEDICAL LIMITED
    Inventors: Benjamin L. Ko, Robert H. Roth, Thomas E. Meyer, Paul D. Gordon, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher
  • Publication number: 20180263815
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: February 15, 2018
    Publication date: September 20, 2018
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 9925088
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: March 27, 2018
    Assignee: Janssen Biotech, Inc.
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Publication number: 20160074211
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, a cannula actuation assembly, and a needle actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The cannula actuation assembly is operable to actuate the cannula relative to the body. The needle actuation assembly is operable to actuate the needle relative to the cannula. The cannula may be inserted through a sclerotomy to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Application
    Filed: August 31, 2015
    Publication date: March 17, 2016
    Inventors: Benjamin L. Ko, Robert H. Roth, Thomas E. Meyer, Paul D. Gordon, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher
  • Publication number: 20150351959
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: June 1, 2015
    Publication date: December 10, 2015
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon